Welcome to our dedicated page for Vital Farms SEC filings (Ticker: VITL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Vital Farms, Inc. (Nasdaq: VITL) is a Certified B Corporation and Delaware public benefit corporation that focuses on pasture-raised eggs and egg-based foods such as shell eggs, butter, hard-boiled eggs, and liquid whole eggs. As a publicly traded company, Vital Farms files regular reports and current reports with the U.S. Securities and Exchange Commission (SEC), providing detailed information on its financial performance, risks, governance, and strategic initiatives.
On this page, you can review Vital Farms’ SEC filings, including annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe its business model, farm network, product categories, and risk factors related to supply, consumer demand, agricultural disease, regulation, and macroeconomic conditions. These filings also discuss its status as a public benefit corporation, its stakeholder-focused objectives, and its emphasis on humane treatment of farm animals and sustainable farming practices.
Current reports on Form 8-K offer more immediate updates. Recent 8-K filings have covered quarterly financial results, long-term net revenue targets, and governance matters such as the appointment of a new independent director and the frequency of advisory Say-on-Pay votes. An amended 8-K explains the company’s decision to hold non-binding advisory votes on executive compensation annually, following stockholder preferences.
Stock Titan’s platform enhances access to these documents with AI-powered summaries that explain key sections of Vital Farms’ filings in plain language. Investors can quickly understand highlights from lengthy 10-K and 10-Q reports, see what management disclosed in 8-K earnings releases, and track governance items without reading every page. Real-time updates from EDGAR ensure that new filings appear promptly, while AI-generated overviews help readers identify significant changes, recurring themes, and references to long-term targets and capital projects.
For users monitoring insider and governance activity, this page also centralizes access to forms and disclosures related to directors and executive compensation policies as referenced in Vital Farms’ filings.
Vital Farms, Inc. (Form 144) proposes the sale of 10,005 shares of common stock through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $461,714.74 against total outstanding shares of 44,685,980. The proposed approximate sale date is 08/12/2025.
The 10,005 shares were acquired by the seller through restricted stock vesting under a registered plan on three dates: 03/10/2024 (5,662), 03/13/2024 (2,882), and 08/09/2024 (1,461). The filing reports "Nothing to Report" for securities sold in the past three months. Several administrative fields in the form (filer CIK/CCC, contact details, issuer address, date of notice, signature) are not provided in the supplied content.
Vital Farms, Inc. submitted a Form 144 reporting a proposed sale of 50,100 common shares with an aggregate market value of $2,312,115.00. The form lists 44,685,980 shares outstanding and an approximate sale date of 08/12/2025 on NASDAQ. The broker named is Morgan Stanley Smith Barney LLC. Acquisition details show 19,552 restricted stock units acquired on 03/10/2023 and 30,548 shares from previously exercised options acquired on 10/12/2023 (the exercised options were paid in cash). No securities were reported sold in the past three months. The filing does not disclose the filer’s CIK or the filer’s relationship to the issuer, which limits the ability to confirm whether this is an affiliate/insider sale.
Vital Farms, Inc. (VITL) filed a Form 144 reporting a proposed sale of 2,811 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ, with an aggregate market value of $127,478.85. The filing lists 44,257,535 shares outstanding, and gives an approximate sale date of 08/11/2025. The notice states the seller acquired the shares through restricted stock vesting under a registered plan on 11/27/2024 (501 shares) and 03/13/2025 (2,310 shares).
The filer reports no securities sold in the past three months and includes the standard representation that the seller does not know any material adverse information about the issuer that has not been publicly disclosed.
Matthew Ohayer, Executive Chairperson, director and 10% owner of Vital Farms, Inc. (VITL), reported planned sales under a Rule 10b5-1 trading plan adopted on March 14, 2025. The Form 4 shows two scheduled sales: 5,000 shares sold on 08/07/2025 at a weighted-average price of $40.31, and 5,000 shares sold on 08/08/2025 at $45.25.
After these reported transactions the filing lists 6,832,070 shares beneficially owned directly by the reporting person. The filing also discloses 716,000 shares held indirectly by a former spouse over which the reporting person has sole voting control but no pecuniary interest. The Form 4 was signed by an attorney-in-fact on 08/11/2025.
Vital Farms insider sale notice: The filing reports a proposed sale of 125,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $5,482,500, scheduled for 08/08/2025 on NASDAQ. The shares were acquired as founders shares on 01/16/2015.
The filing also lists prior 10b5-1 sales attributed to Matthew Ohayer totaling 124,000 shares that generated $4,482,436.50 across seven transactions between 05/19/2025 and 08/07/2025. The proposed 125,000-share sale represents approximately 0.28% of the 44,685,980 shares outstanding.